4.7 Article

Analyzing siRNA Concentration, Complexation and Stability in Cationic Dendriplexes by Stem-Loop Reverse Transcription-qPCR

Journal

PHARMACEUTICS
Volume 14, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/pharmaceutics14071348

Keywords

reverse transcription real-time polymerase chain reaction (RT-qPCR); stem-loop primer; small interfering RNA (siRNA); drug delivery; dendriplexes; nitrogen-to-phosphate (N; P) ratio; ribonuclease A (RNase A) digest

Funding

  1. Ministry of Economics, Labor and Housing BadenWuerttemberg [3-4332.62-HSG/84]

Ask authors/readers for more resources

This article presents a novel approach for quantifying siRNA in drug formulations using reverse transcription real-time PCR (RT-qPCR). The method is highly sensitive and specific, allowing for the quantification of released siRNA and assessment of siRNA stability and concentration inside dendriplexes.
RNA interference (RNAi) is a powerful therapeutic approach for messenger RNA (mRNA) level regulation in human cells. RNAi can be triggered by small interfering RNAs (siRNAs) which are delivered by non-viral carriers, e.g., dendriplexes. siRNA quantification inside carriers is essential in drug delivery system development. However, current siRNA measuring methods either are not very sensitive, only semi-quantitative or not specific towards intact target siRNA sequences. We present a novel reverse transcription real-time PCR (RT-qPCR)-based application for siRNA quantification in drug formulations. It enables specific and highly sensitive quantification of released, uncomplexed target siRNA and thus also indirect assessment of siRNA stability and concentration inside dendriplexes. We show that comparison with a dilution series allows for siRNA quantification, exclusively measuring intact target sequences. The limit of detection (LOD) was 4.2 pM (+/- 0.2 pM) and the limit of quantification (LOQ) 77.8 pM (+/- 13.4 pM) for uncomplexed siRNA. LOD and LOQ of dendriplex samples were 31.6 pM (+/- 0 pM) and 44.4 pM (+/- 9.0 pM), respectively. Unspecific non-target siRNA sequences did not decrease quantification accuracy when present in samples. As an example of use, we assessed siRNA complexation inside dendriplexes with varying nitrogen-to-phosphate ratios. Further, protection of siRNA inside dendriplexes from RNase A degradation was quantitatively compared to degradation of uncomplexed siRNA. This novel application for quantification of siRNA in drug delivery systems is an important tool for the development of new siRNA-based drugs and quality checks including drug stability measurements.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available